Take part in our webinar on Tuesday 10 December at 3PM London / 10AM New...
NSF International has announced it will be exhibiting at Pharma Integrates 2017.
Global vice-president of Pharma Biotech and Medical Devices Martin Lush, and vice-president of Pharma Biotech John Johnson will be at the event and look forward to seeing you there. The company is also delighted to announce Martin has joined the Pharma Integrates steering committee.
This year’s conference will take place from 15 November to 16 November at the Grange City Hotel in London. It will provide a top-tier programme of interviews and interactive debate through led panel discussions, which will focus on the strategic issues facing the drug manufacturing sector and play a vital role in shaping pharma’s future.
On 16 November, Martin will facilitate two panel discussions on how to improve efficiency and effectiveness of pharma research and development (R&D).
Rethinking pharmaceutical productivity (10.05 – 11.05):
This session is all round changing the way pharma thinks about production, processes, and people. As the productivity imperative looms ever larger, companies need to rethink their strategic options and put productivity at the heart of any upcoming change programme or improvement agenda.
De-risking pharma (14:40 – 15:40):
Risk management is a valuable component of an effective quality system, but achieving a shared understanding of the application of risk management is difficult. Given that risk and the effective prediction of risk needs intuitive data interpretation, this session will look beyond the numbers and examine how pharma views, manages, and assesses risk.
Make sure to visit NSF’s stand and get involved in its discussions around ‘how the mighty fall’, identify at what stage your company is, and help recognise the main activities pharmaceutical companies should be doing to prevent organisational decline in this ever-changing and demanding industry.
Book your tickets for the event on the Pharma Integrates website. You will also find the full programme of conference interviews and panel debates including more information on Martin’s sessions. Early bird and multiple delegate discounts are available for a limited period.
Receive 50% off our pharma and medical devices eLearning, £100 off selected one-day courses and...
Interest in Near Patient Testing (NPT) continues to increase momentum as it has a significant...
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs)...